CIK: 1601521 - Address: C/O Centessa Pharmaceuticals Plc, 3Rd Floor, 1 Ashley Rd, Altrincham, Cheshire, X0 WA14 2DT
7 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret1126-75-33-7-0
P%wins500505050033
S%ret111824219-7011
S%wins000010020

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/6/21 17:31
12/2/21
CNTACentessa Pharmaceuticals PlcX0HealthDrugPharmaceutical PreparationsDe Rubertis FrancescoX0DP44012.82034014,187I
12/2/21 17:24
11/30/21
CNTACentessa Pharmaceuticals PlcX0HealthDrugPharmaceutical PreparationsDe Rubertis FrancescoX0DP.m1,18912.24097114,186I
11/30/21 17:26
11/26/21
CNTACentessa Pharmaceuticals PlcX0HealthDrugPharmaceutical PreparationsDe Rubertis FrancescoX0DP.m79711.64069014,184I
6/4/21 17:01
6/2/21
CNTACentessa Pharmaceuticals PlcX0HealthDrugPharmaceutical PreparationsDe Rubertis FrancescoX0DP.d12,00020.000600414,182I
8/12/16 14:40
8/10/16
NERVMinerva Neurosciences, Inc.DEHealthDrugPharmaceutical PreparationsDe Rubertis FrancescoMADTS-10,00010.004-1,000-184,488I54901349350-2-7824219-7
3/20/15 12:43
3/18/15
NERVMinerva Neurosciences, Inc.DEHealthDrugPharmaceutical PreparationsDe Rubertis FrancescoMADTP.d9754.81120345,488I-14352518202-1-12-5-8-4-5
7/9/14 20:03
7/7/14
NERVMinerva Neurosciences, Inc.DEHealthDrugPharmaceutical PreparationsDe Rubertis FrancescoMADTP.d9,7256.0051,621445,286I-113-11539-9

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact